Modulation of Intracellular Cyclic AMP Levels by Different Human Dopamine D4 Receptor Variants

@article{Asghari1995ModulationOI,
  title={Modulation of Intracellular Cyclic AMP Levels by Different Human Dopamine D4 Receptor Variants},
  author={Vida Asghari and Suparna Sanyal and S Buchwaldt and A Paterson and Vera Jovanovic and Hubert H. M. Van Tol},
  journal={Journal of Neurochemistry},
  year={1995},
  volume={65}
}
Abstract: To investigate whether polymorphic forms of the human dopamine D4 receptor have different functional characteristics, we have stably expressed cDNAs of the D4.2, D4.4, and D4.7 isoforms in several cell lines. Chinese hamster ovary CHO‐K1 cell lines expressing D4 receptor variants displayed pharmacological profiles that were in close agreement with previous data from transiently expressed D4 receptors in COS‐7 cells. Dopamine stimulation of the D4 receptors resulted in a concentration… Expand
Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3',5'-monophosphate production does not affect prolactin regulation.
TLDR
It appears that although the D4 receptor may be expressed in the anterior pituitary, it does not have a major effect on PRL promoter activity or PRL secretion in GH4C1 cells despite its ability to reduce cAMP production, which might explain why D4- over D2-preferring antipsychotics such as clozapine do not cause hyperprolactinemia. Expand
Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors
TLDR
Long-term agonist-induced sensitization of adenylate cyclase by the D4 receptor may involve mechanisms that do not contribute to short-term sensitization, implying a role for Gi/Go proteins in heterologous sensitization. Expand
Functional activation by central monoamines of human dopamine D(4) receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes.
TLDR
It is shown that dopamine D(4) receptors can be pharmacologically stimulated by any the three major central monoamines, dopamine, noradrenaline and serotonin. Expand
Functional Analysis of the Human D2 Dopamine Receptor Missense Variants*
TLDR
The demonstration of substantial functional differences between DRD2 gene variants found in the human population might have important pharmacological implications given the widespread use of D2 receptor blocking drugs in the treatment of schizophrenia and other psychiatric disorders. Expand
Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D2 and D4 receptors.
TLDR
Five different dopamine receptor subtypes and alternative splicing variants of dopamine D2 and D4 were examined and it was revealed that the regions containing the SH3-binding domains are responsible for the beta-arrestin translocation. Expand
The agonist activities of the putative antipsychotic agents, L‐745,870 and U‐101958 in HEK293 cells expressing the human dopamine D4.4 receptor
TLDR
Results show that the putative dopamine D 4 receptor antagonists, L‐745,870 and U‐101958 are not devoid of intrinsic activity at human recombinant dopamine D4.4 receptors and may not represent the most appropriate drugs for testing the benefit of D4 receptor antagonism in schizophrenic patients, if agonism should translate in vivo. Expand
Revisiting the Functional Role of Dopamine D4 Receptor Gene Polymorphisms: Heteromerization-Dependent Gain of Function of the D4.7 Receptor Variant
TLDR
This study readdressed the question of functional differences of D4.4R and D.4.7R, providing the first clear mechanism for a functional difference between both products of polymorphic variants and for a gain of function of the D44.5R. Expand
Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs
TLDR
The results of this study suggest that inherited variants of D4 may explain some of the interindividual variation seen in patient response to different classes of antipsychotic medication. Expand
Key role of the dopamine D4 receptor in the modulation of corticostriatal glutamatergic neurotransmission
TLDR
The results demonstrate a key role of the D4 receptor in the modulation of corticostriatal glutamatergic neurotransmission and imply that enhanced D 4 receptor–mediated dopaminergic control of CorticostRIatal transmission constitutes a vulnerability factor of ADHD and other neuropsychiatric disorders. Expand
I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor.
TLDR
The data suggest that NGD 94-1 functions as an antagonist rather than a full or partial agonist at the human D4.2 receptor subtype, and the clinical use of this subtype-specific compound should permit direct evaluation of the role of D4 receptors in psychiatric disorders. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 43 REFERENCES
Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
TLDR
Comparison of the potencies at the two receptors reveals that none of the agonists is as selective for D3 receptors as was previously thought based on radioligand binding data. Expand
Structural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell line.
TLDR
It is reported here that the D2A and D2B structural subtypes constitute functionally distinct forms of the dopamine receptor that can couple to multiple intracellular signalling pathways. Expand
Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion.
TLDR
The data show conclusively that the cDNA clone encodes a functional dopamine-D2 receptor which couples to G-proteins to inhibit adenylyl cyclase and both cAMP-dependent and camp-independent hormone secretion. Expand
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1
TLDR
The cloning of a gene encoding a 477-amino-acid protein with strong homology to the cloned Dt receptor is reported here the existence of a dopamine D1-like receptor with these characteristics had not been predicted and may represent an alternative pathway for dopamine-mediated events and regulation of D2 receptor activity. Expand
Multiple dopamine D4 receptor variants in the human population
TLDR
This is the first report of a receptor in the catecholamine receptor family that displays polymorphic variation in the human population and such variation among humans may underlie individual differences in susceptibility to neuropsychiatric disease and in responsiveness to antipsychotic medication. Expand
Cloning and expression of a rat D2 dopamine receptor cDNA
TLDR
This receptor has been characterized on the basis of three criteria: the deduced amino-acid sequence which reveals that it is a member of the family of G-protein-coupled receptors; the tissue distribution of the mRNA which parallels that of the D2 dopamine receptor; and the pharmacological profile of mouse fibroblast cells transfected with the cDNA. Expand
Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines.
In order to study the properties of the D2-like dopamine receptors, D2, D3 and D4 clones were transfected into mouse Ltk- fibroblasts, CCL1.3, and a neuronal mesencephalic cell line, MN9D. Most ofExpand
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
TLDR
The cloning of a gene that encodes a dopamine receptor gene that has high homology to the human dopamine D2 and D3 receptor genes is reported, which suggests the existence of other types of dopamine receptors which are more sensitive to clozapine. Expand
Complete Conversion of Brain D2 Dopamine Receptors from the High‐ to the Low‐Affinity State for Dopamine Agonists, Using Sodium Ions and Guanine Nucleotide
TLDR
It is concluded that it is possible to convert brain D2 dopamine receptors completely into their low‐affinity state, in the presence of NaCl and a guanine nucleotide, providing that appropriate allowance is made for the serotonergic component of [3H]spiperone binding. Expand
Human dopamine D1 receptor encoded by an intronless gene on chromosome 5
TLDR
The cloning of the D1 receptor gene is reported, which resides on an intronless region on the long arm of chromosome 5, near two other members of the G-linked receptor family, and binds drugs with affinities identical to the native human D1 receptors. Expand
...
1
2
3
4
5
...